Hormone-sensitive Metastatic Breast Cancer
1 clinical trials · Condition
◉ Watch Hormone-sensitive Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer (NCT01205685) | Vanderbilt-Ingram Cancer Center | 2010-05-01 |
Track Hormone-sensitive Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.